{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:44:20Z","timestamp":1788871460074,"version":"build-2803163510"},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T00:00:00Z","timestamp":1414108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"NARSAD Young Investigator Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Early Intervention Psych"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>\n                      It has been found that long\u2010chain omega\u20103 polyunsaturated fatty acids (\n                      <jats:styled-content style=\"fixed-case\">PUFAs<\/jats:styled-content>\n                      ) reduce the risk of progression to first episode of psychosis (\n                      <jats:styled-content style=\"fixed-case\">FEP<\/jats:styled-content>\n                      ) and may offer a safe and efficacious strategy for selective and indicated prevention in young people with ultra\u2010high\u2010risk (\n                      <jats:styled-content style=\"fixed-case\">UHR<\/jats:styled-content>\n                      ) states. An opportunity for exploring the trajectory of\n                      <jats:styled-content style=\"fixed-case\">FEP<\/jats:styled-content>\n                      and for investigating the efficacy of preventive treatments exists in 22q11.2 deletion syndrome (22q11\n                      <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n                      ), which has a 30% psychotic transition rate. The fact that 22q11\n                      <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n                      patients are more homogeneous than other\n                      <jats:styled-content style=\"fixed-case\">UHR<\/jats:styled-content>\n                      groups and are characterized by high level of negative symptoms provides a strong rationale for the use of\n                      <jats:styled-content style=\"fixed-case\">PUFAs<\/jats:styled-content>\n                      . The principal aim of the present trial is to investigate the effects of\n                      <jats:styled-content style=\"fixed-case\">PUFAs<\/jats:styled-content>\n                      in individuals with 22q11\n                      <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n                      who are at\n                      <jats:styled-content style=\"fixed-case\">UHR<\/jats:styled-content>\n                      for developing\n                      <jats:styled-content style=\"fixed-case\">FEP<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective, randomized, double\u2010blind, placebo\u2010controlled, single\u2010centre study design will be used. Eighty individuals aged 12\u201326 will be randomly assigned to two treatment conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The experimental group will receive\n                      <jats:styled-content style=\"fixed-case\">PUFAs<\/jats:styled-content>\n                      . The placebo group will receive paraffin oil. Standard clinical assessments and neuropsychological tests will be performed at baseline and at 8\u2010, 12\u2010, 26\u2010 and 52\u2010week follow\u2010up. Blood samples will be collected at baseline and after 12 weeks. This study is registered as an\n                      <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>\n                      nternational\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      tandard\n                      <jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>\n                      , number 02070211. The corresponding author is supported by a\n                      <jats:styled-content style=\"fixed-case\">NARSAD Y<\/jats:styled-content>\n                      oung\n                      <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>\n                      nvestigator\n                      <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\n                      ward.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This is the protocol of a planned study that aims to test the efficacy of\n                      <jats:styled-content style=\"fixed-case\">PUFAs<\/jats:styled-content>\n                      in the prodromal phase of\n                      <jats:styled-content style=\"fixed-case\">FEP<\/jats:styled-content>\n                      , in a specific syndrome where there is strong evidence that a high genetic load is involved in the disorder.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/eip.12197","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T03:02:46Z","timestamp":1414119766000},"page":"390-396","source":"Crossref","is-referenced-by-count":7,"title":["Indicated prevention with long\u2010chain polyunsaturated omega\u20103 fatty acids in patients with 22q11\n                    <scp>DS<\/scp>\n                    genetically at high risk for psychosis. Protocol of a randomized, double\u2010blind, placebo\u2010controlled treatment trial"],"prefix":"10.1111","volume":"10","author":[{"given":"Marco","family":"Armando","sequence":"first","affiliation":[{"name":"Child and Adolescence Neuropsychiatry Unit Department of Neuroscience Bambino Ges\u00f9 Children's Hospital  Rome Italy"},{"name":"School of Psychology University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"De Crescenzo","sequence":"additional","affiliation":[{"name":"Child and Adolescence Neuropsychiatry Unit Department of Neuroscience Bambino Ges\u00f9 Children's Hospital  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Vicari","sequence":"additional","affiliation":[{"name":"Child and Adolescence Neuropsychiatry Unit Department of Neuroscience Bambino Ges\u00f9 Children's Hospital  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Digilio","sequence":"additional","affiliation":[{"name":"Medical Genetic Unit Pediatric Department Bambino Ges\u00f9 Children's Hospital  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pontillo","sequence":"additional","affiliation":[{"name":"Child and Adolescence Neuropsychiatry Unit Department of Neuroscience Bambino Ges\u00f9 Children's Hospital  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Papaleo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Brain Technologies Istituto Italiano di Tecnologia  Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Paul","family":"Amminger","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry Medical University of Vienna  Vienna Austria"},{"name":"Orygen Youth Health Research Centre Centre for Youth Mental Health University of Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,10,24]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09552"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2841"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90734-K"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1580"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e3181b76683"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs060"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2012.04.020"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijdevneu.2010.09.007"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.07.026"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.192"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.187"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3115"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.10.921"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.185.4.291"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1614.2005.01714.x"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"e_1_2_5_19_1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"e_1_2_5_20_1","volume-title":"Structured Clinical Interview for DSM\u2010IV\u2010TR Axis I Disorders, Research Version, Patient Edition","author":"First MB","year":"2002"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1987.tb10566.x"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.4.549"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867412450470"}],"container-title":["Early Intervention in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Feip.12197","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/eip.12197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T19:43:52Z","timestamp":1695498232000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/eip.12197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,24]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1111\/eip.12197"],"URL":"https:\/\/doi.org\/10.1111\/eip.12197","archive":["Portico"],"relation":{},"ISSN":["1751-7885","1751-7893"],"issn-type":[{"value":"1751-7885","type":"print"},{"value":"1751-7893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,24]]}}}